BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Stock Price, News & Analysis

Company Overview

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$191.74 million
• P/E Ratio: N/A
• Dividend Yield: 3.00%
• Price Target: N/A
• Consensus Rating: N/A

DRUG Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of BetaShares Global Healthcare ETF - Currency Hedged own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BetaShares Global Healthcare ETF - Currency Hedged investors own include Ford Motor (F), Nasstar (NASA), NVIDIA (NVDA), Netflix (NFLX), Duckhorn Portfolio (NAPA), Humana (HUM) and Google Inc. - Common Stock Ex-Distribution When Issued (GOOAV).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Manufacturing
• Industry: Pharmaceutical Preparation Manufacturing
• Sub-Industry: Pharmaceutical Products
• Current Symbol: ASX:DRUG
• CIK: N/A
• Web: N/A
• Phone: (647) 407-2515
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: A$191.74 million
• Optionable: Not Optionable
• Beta: N/A